Seoul-based bio startup, Artblood, has been working to advance veterinary medicine and biomedical research. It specialized in the development of cell-based artificial blood production.
Recently, it achieved a major milestone: the world’s first successful in vitro production of dog blood.
Scientists at Artblood collaborated with Hanyang University and Gyeongsang National University for this milestone.
The successful creation of lab-grown dog blood provides a promising solution for veterinary medicine, offering a reliable and ethical blood supply for transfusions.
Reportedly, researcher Park Seong-ah presented the findings at the CELL BIO 2024 international conference in San Diego.
This conference is a collaborative effort between the American Society for Cell Biology and the European Molecular Biology Organization.
In-vitro blood production is a cutting-edge field in biomedical research that involves cultivating blood cells outside of a living organism. This innovative approach, primarily explored for human medical applications, is now extending its reach to animal health.
…